LLYWatch

Eli Lilly and Co

$1,220.66

Community outlook

Mixed49%

Questions Discussion Earnings Data & analysis

Next report

Wed, 5 Aug 2026

in 7 days

EPS estimate

$6.07

Wall Street consensus

Revenue estimate

$20.9B

Wall Street consensus

Expected swing

±4.4%

±1σ by report day, from realized volatility

Also reporting that week:AMD CAT MCD MRK PFE SPOT DIS MELI

EPS outlook

Odds turned into a number: where the print lands if LLY's usual surprise repeats — and what the crowd's beat odds imply on the same scale.

Street estimate

$•.••

the bar to clear

If history repeats

$•.••

•• of •• quarters beat

Crowd implies

—

needs more forecasts on the beat question

Typical range for the print: $•.•• – $•.••±1σ of past surprises
Beat odds implied by the record: ••%ceiling on •• quarters

A beat probability is a statement about where the print sits relative to the estimate. Scaled by how far recent quarters landed from the Street, it becomes a dollar figure. Not a forecast of the stock — companies fall on beats.

The crowd's read

Live odds from the community — tap through to make your own call.

Will Eli Lilly and Co be higher in 3 months than today?

Nearest crowd call that settles after the report · 6 forecasting

55%

Forecast

The Street's stance

Analyst consensus — and whether it has been improving or souring into the print.

Buy

38 analysts · 30 buy · 7 hold · 1 sell

steady over the last 3 months

Estimate track record

Reported EPS against the Street's estimate, most recent first — the same feed our earnings questions settle on.

Beat rate

4 of 4

quarters beat the estimate

Avg surprise

+18.9%

vs EPS estimate

Quarter	Estimate	Actual	Surprise	Result
Mar 2026	$6.73	$8.55	+27.0%	BEAT
Dec 2025	$6.74	$7.54	+11.9%	BEAT
Sept 2025	$5.75

Fundamentals snapshot

Trailing-twelve-month figures for context around the print.

Market cap

$1.15T

EPS (TTM)

$28.15

P/E (TTM)

45.5

price ÷ trailing earnings

Revenue growth

+47.4%

TTM vs a year ago

Gross margin

82.8%

of revenue kept after costs

Net margin

35.0%

of revenue kept as profit

52-week range

$624 – $1,249

now $1,220.66

Beta

0.50

steadier than the market

Dividend yield

0.49%

Estimates and reported figures via Finnhub; crowd odds are Eli Lilly and Co forecasts on Probs. Information, not investment advice.